Y-mAbs Therapeutics, Inc.

D. E. Shaw & Co., Inc.

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

516,857

Value ($000)

2,331

Weight

0.0%

2019 Q4 - 2025 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	2,331	0.0%	516,857	6/30/2025
2025 Q1	5/15/2025	2,435	0.0%	549,666	3/31/2025
2024 Q4	2/14/2025	4,816	0.0%	615,131	12/31/2024
2024 Q3	11/14/2024	10,356	0.0%	787,536	9/30/2024
2024 Q2	8/14/2024	11,192	0.0%	926,457	6/30/2024
2023 Q4	2/14/2024	9,028	0.0%	1,323,780	12/31/2023
2023 Q3	11/14/2023	7,353	0.0%	1,349,210	9/30/2023
2023 Q2	8/14/2023	8,660	0.0%	1,275,397	6/30/2023
2023 Q1	5/15/2023	3,963	0.0%	790,956	3/31/2023
2022 Q4	2/14/2023	2,287	0.0%	468,664	12/31/2022
2022 Q3	11/14/2022	1,665	0.0%	115,490	9/30/2022
2022 Q2	8/15/2022	626	0.0%	41,387	6/30/2022
2022 Q1	5/16/2022	1,647	0.0%	138,657	3/31/2022
2021 Q2	8/16/2021	1,321	0.0%	39,083	6/30/2021
2021 Q1	5/17/2021	2,433	0.0%	80,465	3/31/2021
2020 Q4	2/16/2021	2,725	0.0%	55,043	12/31/2020
2020 Q3	11/16/2020	451	0.0%	11,740	9/30/2020
2020 Q2	8/14/2020	1,371	0.0%	31,736	6/30/2020
2020 Q1	5/15/2020	535	0.0%	20,500	3/31/2020
2019 Q4	2/14/2020	1,545	0.0%	49,428	12/31/2019